Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hookipa Biotech
Biotech
Hookipa, reeling from Roche's KRAS cull, lays off 30% of team
Roche has waved goodbye to one of its KRAS prospects, terminating an alliance with Hookipa 15 months after betting $25 million on the collaboration.
Nick Paul Taylor
Jan 29, 2024 9:21am
BioMarin CEO replaces commercial chief—Chutes & Ladders
Jan 19, 2024 8:30am
Hookipa halts spending on CMV vaccine after seeing phase 2 data
Mar 15, 2023 9:14am
Roche's executive dominoes continue to tip—Chutes & Ladders
Dec 16, 2022 9:30am
Roche pays Hookipa $25M for multi-KRAS arenaviral immunotherapy
Oct 20, 2022 8:21am
Biogen CEO steps down after Aduhelm blunder—Chutes & Ladders
May 6, 2022 9:30am
